n/a
Abstract Title:

Perspectives for the use of N-acetylcysteine as a candidate drug to treat COVID-19.

Abstract Source:

Mini Rev Med Chem. 2020 Oct 27. Epub 2020 Oct 27. PMID: 33109047

Abstract Author(s):

Pan Luo, Yi Liu, Dong Liu, Juan Li

Article Affiliation:

Pan Luo

Abstract:

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) has become an ongoing pandemic worldwide. However, there are no vaccines or antiviral drugs with proven clinical efficacy. Therefore, a remedial measure is urgently needed to combat with the devastating COVID-19. The pharmacological activities of N-acetylcysteine (NAC) and its potential functions in inhibiting the progression of COVID19 make it a promising therapeutic agent in COVID-19. In this mini-review, we discussed the therapeutic potential of NAC in COVID-19 from the perspective of its multisite pharmacological actions.

Study Type : Review

Print Options


Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2021 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.